The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish Land Regulatory News (BLND)

Share Price Information for British Land (BLND)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 422.60
Bid: 420.60
Ask: 421.60
Change: 13.20 (3.22%)
Spread: 1.00 (0.238%)
Open: 412.00
High: 422.60
Low: 410.80
Prev. Close: 409.40
BLND Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

s430(2B) Companies Act disclosure

11 Jan 2021 09:00

RNS Number : 1491L
British Land Co PLC
11 January 2021
 

Website disclosure in accordance with s430(2B) of the Companies Act 2006

The following information is provided in accordance with section 430(2B) of the Companies Act.

On 10 September 2020 we announced that Chris Grigg would step down from his role as Chief Executive Officer of the British Land Company PLC (the Company) following delivery of the Company's 2021 interim results on 18 November 2020 and leave the Board and the Company on 31 December 2020.

As such, on 31 December 2020 Chris Grigg ceased to be a director of the Company and left the Company. The treatment of his remuneration on cessation has been determined by the Remuneration Committee in line with the terms of the Directors' remuneration policy (as approved by shareholders at the 2019 AGM), details of which are set out below. Full disclosure will also be included in the 2021 Annual Report and Accounts.

Following cessation of employment, he will receive monthly payments in lieu of notice for the remainder of his 12 months' notice period (to 9 September 2021). The total amount payable for the period following ceasing employment for the remainder of the notice period comprises base salary and car allowance of £615,787, pension contributions/allowance of £131,759 and the value of other benefits of £6,066. These payments may be reduced by the value of any alternative paid employment secured during the period until 9 September 2021.

Chris Grigg will also be eligible for an annual bonus for the 2020/21 financial year, subject to the satisfaction of a combination of corporate and personal objectives. The maximum bonus opportunity will be £983,178. Details of the performance achieved against the targets will be set out in the Directors' Remuneration Report. In line with the terms of the Directors' remuneration policy, two-thirds of any annual bonus will be paid in cash and one-third will be used to purchase British Land shares which shall be held on trust for a period of three years.

Chris Grigg will be treated as a "good leaver" under the Company's Long Term Incentive Plan. Consequently, awards will be reduced on a time pro-rata basis and will continue to vest on the normal vesting dates, subject to the extent to which the applicable performance criteria have been met:

1. A maximum of 263,276 Performance Shares may vest under the 2018 LTIP awards; and

2. A maximum of 196,145 Performance Shares may vest under the 2019 LTIP awards; and

3. A maximum of 83,604 Performance Shares may vest under the 2020 LTIP awards.

Vesting levels will be confirmed in the respective Directors' Remuneration Reports, with dividend equivalents being paid in respect of any shares vesting. In line with the Directors' Remuneration Policy, any shares delivered will be subject to a 2 year holding period.

Chris Grigg also holds vested but unexercised LTIP options which were granted in 2011 and 2012. He will have six months following departure to exercise these awards. Awards under the SAYE and SIP all employee plans will also lapse on cessation.

A contribution towards his legal fees of £10,000 plus VAT was provided.

Enquiries:

Analysts & Investors

Joanna Waddingham

 

07714 901166

Media

Charlotte Whitley

 

07887 802535

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKFBDFBKDCDK
Date   Source Headline
27th Jun 20232:00 pmRNSDirector/PDMR Shareholding
23rd Jun 20231:00 pmRNSDirector/PDMR Shareholding
19th Jun 20232:16 pmRNSHolding(s) in Company
16th Jun 202311:00 amRNSDirector/PDMR Shareholding
15th Jun 202312:00 pmRNSDirector/PDMR Shareholding
14th Jun 202312:00 pmRNSHolding(s) in Company
13th Jun 202312:00 pmRNSHolding(s) in Company
9th Jun 20233:54 pmRNSAnnual Financial Report
9th Jun 20232:00 pmRNSHolding(s) in Company
8th Jun 20232:00 pmRNSHolding(s) in Company
2nd Jun 202310:00 amRNSDirector/PDMR Shareholding
31st May 20233:00 pmRNSTotal Voting Rights
30th May 20237:00 amRNSDirector/PDMR Shareholding
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSDirector/PDMR Shareholding
19th May 20232:00 pmRNSHolding(s) in Company
17th May 20237:00 amRNSFinal Results
16th May 202312:00 pmRNSDirector/PDMR Shareholding
5th May 20233:00 pmRNSHolding(s) in Company
28th Apr 20231:29 pmRNSTotal Voting Rights
18th Apr 20232:15 pmRNSDirector/PDMR Shareholding
11th Apr 202311:00 amRNSBlock listing Interim Review
11th Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 202310:00 amRNSHolding(s) in Company
31st Mar 20239:00 amRNSTotal Voting Rights
30th Mar 20233:53 pmRNSHolding(s) in Company
29th Mar 202312:00 pmRNSHolding(s) in Company
16th Mar 20233:30 pmRNSDirector/PDMR Shareholding
10th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Feb 20232:00 pmRNSTotal Voting Rights
15th Feb 20234:00 pmRNSDirector/PDMR Shareholding
31st Jan 202312:57 pmRNSTotal Voting Rights
17th Jan 20231:56 pmRNSDirector/PDMR Shareholding
10th Jan 202312:00 pmRNSDirector/PDMR Shareholding
5th Jan 20232:00 pmRNSDirector/PDMR Shareholding
30th Dec 20229:55 amRNSTotal Voting Rights
16th Dec 20222:30 pmRNSDirector/PDMR Shareholding
30th Nov 20223:00 pmRNSTotal Voting Rights
18th Nov 20227:10 amRNSDirector Declaration
16th Nov 20227:00 amRNSHalf-year Report
15th Nov 202212:00 pmRNSDirector/PDMR Shareholding
31st Oct 20223:52 pmRNSDirector/PDMR Shareholding
31st Oct 20223:31 pmRNSTotal Voting Rights
18th Oct 20222:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:00 pmRNSBlock listing Interim Review
30th Sep 202212:00 pmRNSTotal Voting Rights
16th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 20223:30 pmRNSDirector/PDMR Shareholding
31st Aug 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.